Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Prostemics Co., Ltd.
  6. News
  7. Summary
    A203690   KR7203690003

PROSTEMICS CO., LTD.

(A203690)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Tranche Update on Prostemics Co., Ltd.'s Equity Buyback Plan announced on August 11, 2017.

11/17/2017 | 12:03am EDT

From August 10, 2017 to September 30, 2017, the company has repurchased 1,280,000 shares, representing 2.83% for KRW 3,295.61 million. With this, the company has completed the repurchase of 1,280,000 shares, representing 2.83% for KRW 3,295.61 million under the buyback announced on August 11, 2017.


ę S&P Capital IQ 2017
All news about PROSTEMICS CO., LTD.
08/12California weed supplier HERBL in talks to go public via SPAC merger - source..
RE
08/12California weed supplier HERBL in talks to go public via SPAC merger - source..
RE
06/21Investors brace for annual Russell index rebalancing with pandemic imprint
RE
06/18Investors brace for annual Russell index rebalancing with pandemic imprint
RE
2020Prostemics Co., Ltd. announced that it has received KRW 24 billion in funding..
CI
2020Prostemics Co., Ltd. announced that it expects to receive KRW 24 billion in f..
CI
2018Tranche Update on Prostemics Co., Ltd.'s Equity Buyback Plan announced on Aug..
CI
2018Prostemics Co., Ltd.'s Equity Buyback announced on August 10, 2017, has expir..
CI
2017Tranche Update on Prostemics Co., Ltd.'s Equity Buyback Plan announced on Aug..
CI
2017Prostemics Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth ..
CI
More news
Financials
Sales 2020 20 727 M 17,5 M 17,5 M
Net income 2020 -7 265 M -6,12 M -6,12 M
Net Debt 2020 18 176 M 15,3 M 15,3 M
P/E ratio 2020 -27,2x
Yield 2020 -
Capitalization 139 B 118 M 117 M
EV / Sales 2019 20,4x
EV / Sales 2020 10,4x
Nbr of Employees 83
Free-Float 65,5%
Chart PROSTEMICS CO., LTD.
Duration : Period :
Prostemics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Eun-Wook Choi Co-Chief Executive Officer & Director
Byung-Soon Park Co-Chief Executive Officer & Director
Dong-Young Son Independent Director
Young-Tae Kang Independent Director
Won-Jong Lee Director
Sector and Competitors
1st jan.Capi. (M$)
PROSTEMICS CO., LTD.-29.89%118
L'ORÉAL23.10%250 458
KAO CORPORATION-14.53%29 376
SHISEIDO COMPANY, LIMITED10.87%28 763
NATURA &CO HOLDING S.A.-8.38%12 494
AMOREPACIFIC CORPORATION-7.77%9 993